Annovis Bio, Inc. logo

Annovis Bio, Inc.

Transforming how we treat Alzheimer’s, Parkinson’s, and beyond.

12 employees · est. 2008 · Malvern, United States

VS
Kezar Life Sciences logo

Kezar Life Sciences

Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders

71 employees · est. 2015 · South San Francisco, United...

Annovis Bio, Inc. is the older company (2008 vs 2015); Kezar Life Sciences is the larger of the two.

Side-by-Side Comparison

Annovis Bio, Inc. Kezar Life Sciences
Founded
2008 older 2015
Headquarters
Malvern, United States South San Francisco, United States
Employees
12 71 larger
Industry
Biotechnology, Health and Wellness, Platforms Health Care, Health and Wellness, Life Sciences
Funding Stage
IPO Post Ipo Equity
Total Funding
$121.02M $135.16M
Funding Rounds
13 5
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Annovis Bio, Neurodegenerative Diseases, Alzheimer's Disease, Parkinson's Disease, ANVS-401, Posiphen, BNC, Clinical Stage, Drug Platform Company, Neurotoxic Proteins, Phase 2a Study, Neurological Disorders, Brain Penetrant Inhibitor, Traumatic Brain Injury, Stroke Autoimmune Disease, Immunology, Oncology, Drug Discovery, Drug Development, Clinical-stage Biotechnology, Small-molecule Therapies, Immune-mediated Disorders, Oncologic Disorders, Protein Homeostasis, Protein Degradation, Cellular Function, Master Regulators, Intracellular Regulators
Website
annovisbio.com kezarlifesciences.com
Annovis Bio, Inc. logo

About Annovis Bio, Inc.

Annovis Bio, Inc. is a promising player in the biotechnology industry, with a compelling slogan emphasizing the urgency for a new approach in treating Alzheimer’s, Parkinson’s, and related neurodegenerative diseases. Established in 2008 and headquartered in the United States, the company has recentl...

Kezar Life Sciences logo

About Kezar Life Sciences

Kezar Life Sciences is a clinical-stage biotechnology company founded in 2015 in the United States, focusing on the development of novel, first-in-class, small-molecule therapies for immune-mediated and oncologic disorders. The company's slogan "Pioneering first-in-class, small-molecule therapies fo...

We will tell you when either one moves

BounceWatch watches Annovis Bio, Inc. and Kezar Life Sciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Annovis Bio, Inc. and Kezar Life Sciences — by email.

Frequently Asked Questions

Annovis Bio, Inc. — Transforming how we treat Alzheimer’s, Parkinson’s, and beyond.. Kezar Life Sciences — Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Annovis Bio, Inc. has raised $121.02M while Kezar Life Sciences has raised $135.16M.
Annovis Bio, Inc. and Kezar Life Sciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Annovis Bio, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Annovis Bio, Inc. on 9 Jun 2026, and Kezar Life Sciences on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes